CRISPR Therapeutics AG (CRSP) Balance Sheet Annual - Discounting Cash Flows
CRSP
CRISPR Therapeutics AG
CRSP (NASDAQ)
Period Ending: 2025
12-31
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
Report Filing: 2026-02-12 2025-02-11 2024-02-21 2023-02-21 2022-02-15 2021-02-16 2020-02-12 2019-02-25 2018-03-08 2017-03-10 2015-12-31 2014-12-31
Total Current Assets 1,986 1,937 1,908 1,853 2,418 1,717 987.5 466.4 248.4 320.2 156.8 0.968
Cash and Short Term Investments 1,976 1,904 1,694 1,815 2,379 1,690 943.8 456.6 239.8 315.5 156 0.945
Cash & Equivalents 355.2 298.3 389.5 211.9 923 1,169 943.8 456.6 239.8 315.5 156 0.945
Short Term Investments 1,628 1,606 1,304 1,603 1,456 521.7 0 0 0 0 0 0
Receivables 0 25 200 0 0.305 10.84 0.099 0.088 2.63 3.16 0.339 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 9.84 8.31 14.39 37.71 38.08 15.44 43.68 9.66 6 1.51 0.54 0.023
Total Assets 2,265 2,242 2,230 2,243 2,752 1,828 1,067 489 271.3 345 159.4 1.53
Total Non-Current Assets 279.6 304.9 321.5 390 334.4 111.3 79.2 22.62 22.96 24.77 2.58 0.559
Property, Plant and Equipment 247.6 277.6 305.9 320.6 312 93.03 72.83 18.5 18.86 21.03 1.33 0
Goodwill and Intangible Assets 0 0 0.016 0.071 0.125 0.18 0.235 0.289 0.344 0.399 0.454 0.509
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0.016 0.071 0.125 0.18 0.235 0.289 0.344 0.399 0.454 0.509
Long Term Investments 0 0 1.97 53.13 0 0 5.04 3.16 3.15 3.15 0.7 0
Deferred Tax Assets 0 0 0 0 0 0 -5.04 -3.16 -3.15 -3.15 -0.7 0
Other Long Term Assets 32 27.35 13.57 16.27 22.2 18.14 6.14 3.83 3.76 3.35 0.801 0.05
Total Current Liabilities 149.1 87.78 108.8 121.1 119.9 94.26 57.11 27.75 14.51 22 10.15 2.15
Accounts Payable 11.14 14.71 38.15 27.43 14.82 9.09 5.94 5.07 1.64 4.57 1.58 0.211
Notes Payable/Short Term Debt 18.58 17.29 15.62 15.84 12.16 11.36 8.49 0 0 0 0 0
Tax Payables 0 0.451 0 0 0 10.47 0.583 0.402 0.347 0.023 0.081 0.011
Deferred Revenue 15.77 3.85 4.11 0 1.01 2.34 0.96 0 0 0 0 0
Other Current Liabilities 103.6 51.49 50.91 77.84 91.9 60.99 41.13 22.27 12.53 17.41 8.49 1.92
Total Liabilities 343.4 310 346.8 367.6 352.4 163.7 127.3 96.82 83.51 112.1 188.5 8.5
Total Non-Current Liabilities 194.3 222.2 238 246.5 232.5 69.47 70.22 69.08 69 90.12 113.9 0.085
Total Long Term Debt 376.3 206.4 223 228.2 212.9 50.07 44.05 0 0 0 -26.18 0
Deferred Tax Liabilities Non-Current 0 0 0 0 0 0 0 0 0 0 64.52 0
Deferred Revenue Non-Current 0 12.32 14.01 12.32 12.32 11.78 11.78 57.78 56.93 77.65 75.09 0
Capital Lease Obligations 188.2 206.4 223 228.2 212.9 50.07 44.05 0 0 0 -64.52 0
Other Long Term Liabilities -370.2 -203 -222 -222.2 -205.5 -42.44 -29.66 11.29 12.07 12.47 64.97 0.085
Total Equity 1,922 1,932 1,883 1,875 2,399 1,664 939.4 392.2 187.8 232.8 -29.12 -6.97
Non-Controlling Interest 0 0 0 0 0 0 0 0 0 0 -0.027 0.143
Total Stockholders' Equity 1,922 1,932 1,883 1,875 2,399 1,664 939.4 392.2 187.8 232.8 -29.1 -7.12
Retained Earnings -1,948 -1,366 -999.7 -846.1 -195.9 -573.6 -224.7 -291.6 -125.4 -57.08 -33.91 -8.4
Accumulated Other Earnings 4.82 1.84 1.91 -15.65 -5.07 -0.083 0.007 -0.008 0.014 -0.026 -0.008 -0.002
Common Stock 3.09 2.7 2.5 2.44 2.39 2.28 1.85 1.58 1.24 1.22 0.181 0.12
Preferred Stock 0 0 0 0 0 0 0 0 0 0 64.52 6.27
Additional Paid in Capital 3,861 3,293 2,878 2,735 2,598 2,236 1,162 682.2 312 288.7 -64.52 -6.27
Total Liabilities & Total Equity 2,265 2,242 2,230 2,243 2,752 1,828 1,067 489 271.3 345 159.4 1.53
Total Liabilities & Shareholders' Equity 2,265 2,242 2,230 2,243 2,752 1,828 1,067 489 271.3 345 159.4 1.53
Total Investments 1,628 1,606 1,306 1,657 1,456 521.7 5.04 3.16 3.15 3.15 0.7 0
Total Debt 394.9 223.7 238.6 244 225 61.43 52.54 0 0 0 38.34 0
Net Debt 39.73 -74.56 -150.8 32.14 -698 -1,107 -891.2 -456.6 -239.8 -315.5 -117.6 -0.945
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program